Publication of Financial results for the quarter ended June 2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Shukra Pharmaceuticals Ltd has informed BSE that its unaudited standalone financial results for the quarter ended June 30, 2025 were published in two newspapers — Business Standard (English) and Jai Hind (Gujarati) — as required under SEBI Listing Regulations. The filing is signed by Director Bhoomiben Patel and includes copies of the published results for record. No actual financial figures or performance details are disclosed in this filing itself, only the fact of newspaper publication. The company is based in Ahmedabad, Gujarat, and operates in the pharmaceutical sector.
This is a routine regulatory compliance filing with no direct impact on share price or shareholder value. Investors seeking the actual Q1 performance numbers should refer to the published newspaper results or the company's separate financial results filing.